BD (Becton, Dickinson and Company) celebrated 70 years of manufacturing in Sandy, Utah, where it produces essential medical devices like peripheral IV catheters used globally in patient care. The facility employs over 1,000 people and has seen more than $100 million invested recently to expand and modernize operations, reflecting BD's commitment to U.S. manufacturing and healthcare innovation. This milestone highlights BD's role in advancing medical technology and supporting local communities through grants and partnerships. Going forward, BD continues to innovate in vascular access technology and strengthen its presence in Utah's healthcare sector.
BDX shares trade at USD 184.18 on Pluang as of Sep 29, 2026 20:14 WIB, showing a modest 0.19% gain in the last day. The stock's market cap stands at $50.07 billion, reflecting strong investor confidence in BD's long-term innovation and manufacturing presence. This aligns with BD's recent $100 million investment to expand its Sandy, Utah facility, marking 70 years of continuous operation and community partnership.
